ArticleNeuro-oncology advances

Modeling tumor volume trajectory and outcome identifies 3 distinct response classes in lower-grade IDH-mutant glioma receiving first-line chemotherapy.

Amélie Darlix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.